These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37982094)

  • 1. Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study.
    Jiang F; Tian L; Fu H; Hasegawa T; Wei LJ
    J Am Stat Assoc; 2019; 114(528):1854-1864. PubMed ID: 37982094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study.
    Tian L; Jiang F; Hasegawa T; Uno H; Pfeffer M; Wei LJ
    Stat Med; 2019 Mar; 38(6):917-932. PubMed ID: 30352486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial.
    Tian L; Cai T; Zhao L; Wei LJ
    Biostatistics; 2012 Apr; 13(2):256-73. PubMed ID: 22294672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robustness of ANCOVA in randomized trials with unequal randomization.
    Bartlett JW
    Biometrics; 2020 Sep; 76(3):1036-1038. PubMed ID: 31823345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
    Wang B; Ogburn EL; Rosenblum M
    Biometrics; 2019 Dec; 75(4):1391-1400. PubMed ID: 31009064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.
    Wan F
    Stat Methods Med Res; 2019; 28(10-11):2952-2974. PubMed ID: 30084297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score weighting for covariate adjustment in randomized clinical trials.
    Zeng S; Li F; Wang R; Li F
    Stat Med; 2021 Feb; 40(4):842-858. PubMed ID: 33174296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landmark estimation of survival and treatment effects in observational studies.
    Parast L; Griffin BA
    Lifetime Data Anal; 2017 Apr; 23(2):161-182. PubMed ID: 26880366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation with interval censored data and covariates.
    Van der Laan MJ; Hubbard A
    Lifetime Data Anal; 1997; 3(1):77-91. PubMed ID: 9384627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing pre-post designs using the analysis of covariance models with and without the interaction term in a heterogeneous study population.
    Wan F
    Stat Methods Med Res; 2020 Jan; 29(1):189-204. PubMed ID: 30757963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative double robust targeted maximum likelihood estimation.
    van der Laan MJ; Gruber S
    Int J Biostat; 2010 May; 6(1):Article 17. PubMed ID: 20628637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing treatment allocation in randomized clinical trials by leveraging baseline covariates.
    Zhang W; Zhang Z; Liu A
    Biometrics; 2023 Dec; 79(4):2815-2829. PubMed ID: 37641532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust estimation for partially linear models with large-dimensional covariates.
    Zhu L; Li R; Cui H
    Sci China Math; 2013 Oct; 56(10):2069-2088. PubMed ID: 24955087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of auxiliary covariates in estimating a biomarker-adjusted treatment effect model with clinical trial data.
    Zhang Z; Qu Y; Zhang B; Nie L; Soon G
    Stat Methods Med Res; 2016 Oct; 25(5):2103-2119. PubMed ID: 24346166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.